DelveInsight s, Encephalopathy Pipeline Insight 2024 report provides comprehensive insights about 70+ Encephalopathy companies and 70+ pipeline drugs in the Encephalopathy pipeline landscape. It.
Axcella Health Inc. (NASDAQ:AXLA – Get Free Report) was the target of a significant decrease in short interest during the month of October. As of October 31st, there was short interest totalling 78,200 shares, a decrease of 30.7% from the October 15th total of 112,900 shares. Based on an average trading volume of 962,800 shares, […]